InvestorsHub Logo
Followers 3
Posts 720
Boards Moderated 0
Alias Born 07/12/2016

Re: Fmello post# 7255

Saturday, 05/14/2022 1:50:22 AM

Saturday, May 14, 2022 1:50:22 AM

Post# of 7486
So with the approval of Recell and the JAK inhibitor for vitiligo suddenly 6 million people in this country would be eligible for treatment. If only 5% of those get treated it will represent an almost $2 billion new income stream for Avita. And that's not pie in the sky, this will happen for Recell next year and a similar time frame for the JAK inhibitor.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News